Posts

This week IIBB-CSIC has celebrated the Science Week with conferences and workshops for highschoolers. For that, María, Júlia and Alejandro prepared and delivered a workshop on microscopy where they demonstrated the use of different microscopy platforms and visualized normal and disease tissues.

This week IIBB-CSIC has celebrated the Science Week with conferences and workshops for highschoolers. TRFC Lab did not want to miss the opportunity to inspire the next generation of scientists. For that, Júlia and Alejandro prepared and delivered a workshop on microscopy to nine different groups of students where they visualized normal and disease tissues and learn about fibrotic disease and cancer.

This week Maria and Anna have attended to the 2nd International Conference in Liver and Gut Fibrosis. It was an excellent meeting where we had the chance to listen about the latest research advances on liver and gut fibrosis.

Paco de Leon interviewed Anna Moles in his radio program “De cero al Infinito” at Onda Cero. Anna shared our team’s latest research on liver fibrosis resolution with his audience. Listen to the interview in here from minute 39:

Our new research article published at Molecular Metabolism has had a excellent reception in the media and has created lots of interest. You can check the news coverage below: https://www.csic.es/es/actualidad-del-csic/un-trabajo-identifica-el-papel-de-una-proteina-celular-en-la-remision-de-la-fibrosis https://delegacion.

We are delighted to share that our paper “Cathepsin D is essential for the degradomic shift of macrophages required to resolve liver fibrosis” is in press now in Molecular Metabolism! Liver fibrosis is largely acknowledged to be reversible but little is known about the mechanisms controlling ECM remodeling during resolution.

Dr Anna Moles and Paloma Ruiz present the newest research from the TRFCLab in the topic “Phenotypical degradative shift of macrophages, an emerging concept fibrosis resolution” at the 6a Reunión of Hepatologia Translacional AEEH.

Dr Pistorio, who is a former member and is currently working as a postdoctoral researcher at Centre de Recherche Saint Antoine (CRSA), Paris Ile-de-France, France visited and shared with us the latest progress of her research.

We are excited to share our latest review exploring the potential of lysosomal cathepsins as therapeutic targets for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) and Hepatocellular Carcinoma (HCC): https://www.explorationpub.com/Journals/edd/Article/100559